Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a

利用 CNP-miR146a 靶向炎症和氧化应激治疗急性肺损伤

基本信息

  • 批准号:
    10382076
  • 负责人:
  • 金额:
    $ 29.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY - Acute respiratory distress syndrome (ARDS) accounts for 10% of ICU admissions worldwide with a mortality as high as 46%. This incidence has risen dramatically in the last year due to the novel coronavirus (SARS-CoV-2) causing COVID-19, and ARDS is the leading cause of death in COVID-19 patients. In the United States, COVID-19 has infected over 30 million and killed 550,000 people already. Despite improvements in critical care and early detection of lung injury, the management of ARDS remains largely supportive, and while mechanical ventilation may provide the necessary life support, impaired pulmonary mechanics and subsequent ventilator induced lung injury (VILI) can impose a second insult that worsens outcomes. A range of systemic inflammatory insults, including trauma, sepsis, COVID-19, or local injury from toxic exposure, are associated with acute lung injury (ALI) and the development of ARDS, and result in alterations in lung compliance and lung fibrosis. While the etiology of ALI is multifactorial, a central pathogenic feature is a persistent activation of inflammation and oxidative stress. Following ALI, lung macrophages produce pro- inflammatory cytokines that result in the recruitment of additional inflammatory cells and the generation of reactive oxygen species (ROS). This pro-inflammatory state is regulated by key pro-inflammatory cytokines such as interleukin-6 (IL-6) and IL-8 which are stimulated by NFkB, a pro-inflammatory transcription factor. An additional layer of control of inflammation is through miR-146a, a regulatory microRNA that serves as a “molecular brake” on inflammation through inhibition of NFkB activation and downstream IL-6 and IL-8 expression. Ceria Therapeutics has developed a novel strategy to synergistically target both inflammation and oxidative stress. Novel cerium oxide nanoparticles (CNPs) have been designed and synthesized that possess ROS scavenging properties, conjugated with an anti-inflammatory miR-146a mimetic (CNP-miR146a), to target both ROS and the inflammatory response. In compelling preliminary data in a bleomycin-induced model of ALI, It was found that one-time administration of CNP-miR146a at the time of injury prevents inflammation and fibrosis and results in improved pulmonary mechanics. However, the ability to rescue lung injury and improve pulmonary mechanics after injury has occurred remain to be determined. Based on our hypothesis that CNP-miR146a will rescue ALI by reducing inflammation and oxidative stress, decrease fibrosis, and thus improve pulmonary mechanics, the objective of this proposal is to demonstrate the efficacy of our especially formulated form of CNP-miR146a for intratracheal delivery (CTX-002) to rescue existing ALI in two clinically relevant ALI animal models and to carry out a pilot safety assessment. The efficacy of CTX-002 in i) will be evaluated in a VILI-induced ALI model (Specific Aim 1) and ii) a two-hit model of live bacterial infection (S. aureus) followed by VILI (Specific Aim 2). In Specific Aim 3 an acute 7-day tolerability and toxicokinetic study in rats as a pilot safety assessment will be carried out.
项目总结-急性呼吸窘迫综合征(ARDS)占ICU住院患者的10%

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Jackson其他文献

David Jackson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Jackson', 18)}}的其他基金

Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a
利用 CNP-miR146a 靶向炎症和氧化应激治疗急性肺损伤
  • 批准号:
    10758905
  • 财政年份:
    2022
  • 资助金额:
    $ 29.93万
  • 项目类别:
A Novel Anti-inflammatory and Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers
一种治疗不愈合糖尿病足溃疡的新型抗炎和抗氧化疗法
  • 批准号:
    10600900
  • 财政年份:
    2022
  • 资助金额:
    $ 29.93万
  • 项目类别:

相似海外基金

Contributions of cell behaviours to dorsal closure in Drosophila abdomen
细胞行为对果蝇腹部背侧闭合的贡献
  • 批准号:
    2745747
  • 财政年份:
    2022
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Studentship
Using the GI Tract as a Window to the Autonomic Nervous System in the Thorax and in the Abdomen
使用胃肠道作为胸部和腹部自主神经系统的窗口
  • 批准号:
    10008166
  • 财政年份:
    2018
  • 资助金额:
    $ 29.93万
  • 项目类别:
Development of a free-breathing dynamic contrast-enhanced (DCE)-MRI technique for the abdomen using a machine learning approach
使用机器学习方法开发腹部自由呼吸动态对比增强 (DCE)-MRI 技术
  • 批准号:
    18K18364
  • 财政年份:
    2018
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Combined motion-compensated and super-resolution image reconstruction to improve magnetic resonance imaging of the upper abdomen
结合运动补偿和超分辨率图像重建来改善上腹部的磁共振成像
  • 批准号:
    1922800
  • 财政年份:
    2017
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Studentship
Optimising patient specific treatment plans for ultrasound ablative therapies in the abdomen (OptimUS)
优化腹部超声消融治疗的患者特定治疗计划 (OptimUS)
  • 批准号:
    EP/P013309/1
  • 财政年份:
    2017
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Research Grant
Optimising patient specific treatment plans for ultrasound ablative therapies in the abdomen (OptimUS)
优化腹部超声消融治疗的患者特定治疗计划 (OptimUS)
  • 批准号:
    EP/P012434/1
  • 财政年份:
    2017
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Research Grant
Relationship between touching the fetus via the abdomen of pregnant women and fetal attachment based on changes in oxytocin levels
基于催产素水平变化的孕妇腹部触摸胎儿与胎儿附着的关系
  • 批准号:
    16K12096
  • 财政年份:
    2016
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design Research of Healthcare System based on the Suppleness of Upper Abdomen
基于上腹部柔软度的保健系统设计研究
  • 批准号:
    16K00715
  • 财政年份:
    2016
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Technical Development of Diffusion Tensor Magnetic Resonance Imaging in the Human Abdomen
人体腹部弥散张量磁共振成像技术进展
  • 批准号:
    453832-2014
  • 财政年份:
    2015
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Postdoctoral Fellowships
Technical Development of Diffusion Tensor Magnetic Resonance Imaging in the Human Abdomen
人体腹部弥散张量磁共振成像技术进展
  • 批准号:
    453832-2014
  • 财政年份:
    2014
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Postdoctoral Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了